Kyntra Bio, Inc. (KYNB)
Nasdaq: KYNB · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2002
Who owns Kyntra Bio, Inc.
As filed with the SECHolders of 5% or more
1
Armistice Capital, LLC holds 9.88% of Common Stock, $0.01 par value, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
7
report now, of 29 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · 9.88% in May 15, 2026
Primecap Management Co/ca/
SCHEDULE 13G/A · filed Feb 13, 2025 · COM · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Jul 29, 2025 · Common Stock · reported falling below 5%
What KYNB reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Fibro Gen Cayman
An entity · legal entity · owns, named in the 10-K filed Mar 16, 2026
Fibrogen Europe Oy
An entity · legal entity · owns, named in the 10-K filed Mar 16, 2026
Kyntra Bio
An entity · legal entity · owns, named in the 10-K filed Mar 16, 2026
5 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 16, 2026.
Insider tradesForm 4
0sales
4purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Oct 6, 2025 to Oct 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Wettig Thane | CEO | 0 | $0 | 0 | 4 | $100,000 |